Home / stamps / FDA Approval Draws Higher Price Target For Bristol-Myers

FDA Approval Draws Higher Price Target For Bristol-Myers

Goldman Sachs maintains buy rating after agency rubber-stamps melanoma treatment.

More: continued here

About admin

Check Also

Japan to introduce forgery-proof revenue stamps – NHK WORLD

Japan to introduce forgery-proof revenue stampsNHK WORLDJapan's National Tax Agency will introduce anti-counterfeit revenue stamps …

Leave a Reply

Your email address will not be published. Required fields are marked *